The effects of finasteride on hematuria associated with benign prostatic hyperplasia: a preliminary report.

Abstract

PURPOSE:

The efficacy of finasteride was assessed in the treatment of gross hematuria associated with benign prostatic hyperplasia (BPH).

MATERIALS AND METHODS:

A retrospective review was done of 18 patients who had been placed on finasteride (5 mg . daily) for the treatment of gross hematuria associated with BPH. A hematuria grading system was devised.

RESULTS:

Of the 12 patients with longer than 3 months of followup (mean 14) 11 improved according to the grade of hematuria after finasteride therapy.

CONCLUSIONS:

Finasteride is effective in treating hematuria associated with BPH. This finding is especially relevant for patients with multiple medical problems and anesthetic risks.

• Authors: P J Puchner, M I Miller
• Journal: The Journal of urology (J Urol) Vol. 154 Issue 5 Pg. 1779-82 (Nov 1995) ISSN: 0022-5347 [Print] United States
• PMID: 7563345 (Publication Type: Journal Article)

Chemical References

• Enzyme Inhibitors
• Finasteride

Topics

• Aged
• Aged, 80 and over
• Enzyme Inhibitors (therapeutic use)
• Finasteride (therapeutic use)
• Hematuria (drug therapy, etiology)
• Humans
• Male
• Prostatic Hyperplasia (complications)
• Retrospective Studies